BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Novotech Launches Early Phase Unit for Biotechs in Australian and New Zealand Clinical Environment

Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and n...

June 14, 2024 | News

LumaCina to Produce Oral Morphine Amidst Critical Shortage in New Zealand

LumaCina, the pharmaceutical supplier and marketing division of Bridgewest Perth Pharma announce new production of Oral Morphine to meet cr...

May 31, 2024 | News

Grindr and Burnett Foundation Aotearoa Partner to Distribute Free HIV Test Kits in New Zealand

Grindr and Burnett Foundation Aotearoa Partner to Distribute Free HIV Test Kits in New Zealand Grindr Inc. (NYSE: GRND), the leading social networ...

March 25, 2024 | News

Lunit's Bid to Acquire Volpara Gains Momentum with New Zealand High Court's Initial Nod

Volpara Health Technologies (Volpara; ASX:VHT), renowned for its AI-driven solutions in cancer diagnostics, is on the brink of a transformative merger with...

March 14, 2024 | News

Bridging Gaps, Building Futures: Ruth Kuguru’s Approach to Healthcare Solutions in APAC

In this insightful interview with BioPharma APAC, Ruth Kuguru, Executive Director of Communications & Engagement at Novartis for Asia Pacific, Middle E...

March 05, 2024 | Interaction

Sparsentan Receives CHMP Endorsement for IgA Nephropathy Treatment in Europe

CSL Vifor together with Travere Therapeutics, Inc., disclosed that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CH...

February 26, 2024 | News

AIRS Medical Partners with ParagonCare to Boost SwiftMR™ Sales in Australia and New Zealand

AIRS Medical Inc., a leading provider of AI-powered healthcare solutions, has announced a strategic partnership agreement with ParagonCare Limited&nbs...

February 19, 2024 | News

Molecule AI Spearheads Pharmaceutical Transformation with AI-Driven Drug Discovery Innovations

Molecule AI, on a mission to accelerate drug discovery through the innovative use of artificial intelligence, is making significant...

January 20, 2024 | News

Biocon Biologics Successfully Integrates Acquired Biosimilars Business Across 120 Countries

Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully conc...

December 19, 2023 | News

MGI Australia Introduces Innovative CEC with DCS Lab Products for Advanced DNA, Cell, and Spatial-omics Technology

MGI Australia, a subsidiary of MGI Tech Co. Ltd. (MGI), a global leader in life science technology, is delighted to announce a substantial expans...

December 15, 2023 | News

Specialised Therapeutics Secures Exclusive License for Novel Ovarian Cancer Treatment from CanariaBio

First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab in combination with chemotherapy improved progress...

October 13, 2023 | News

EQT's Acquisition: VetPartners, Key Animal Health Provider in Australia and New Zealand

EQT to acquire VetPartners, the leading provider of veterinary and animal health services across a network of 267 general practice clinics and specialty ...

October 12, 2023 | News

Specialised Therapeutics acquires commercialisation rights to new oral MND therapy

ST to partner with Dutch biotech company Treeway BV First CNS therapy in ST therapeutic portfolio The therapy is known as TW001 and is a un...

August 28, 2023 | News

First Patient Dosed in TLX101 Brain Cancer Study for Newly Diagnosed Glioblastoma

IPAX-2 (ClinicalTrials.gov Identifier: NCT05450744) is a Phase I dose escalation study to confirm safety profile of TLX101 in combination with externa...

August 08, 2023 | News

Stay Connected